Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06112522
Title Tirbanubulin (Klisiry) in the Treatment of Basal Cell Carcinoma
Acronym Tirbaso
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Hospitalier Universitaire de Nice
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.